Cargando…
Translocation of (ultra)fine particles and nanoparticles across the placenta; a systematic review on the evidence of in vitro, ex vivo, and in vivo studies
Fetal development is a crucial window of susceptibility in which exposure may lead to detrimental health outcomes at birth and later in life. The placenta serves as a gatekeeper between mother and fetus. Knowledge regarding the barrier capacity of the placenta for nanoparticles is limited, mostly du...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607677/ https://www.ncbi.nlm.nih.gov/pubmed/33138843 http://dx.doi.org/10.1186/s12989-020-00386-8 |
_version_ | 1783604688551149568 |
---|---|
author | Bongaerts, Eva Nawrot, Tim S. Van Pee, Thessa Ameloot, Marcel Bové, Hannelore |
author_facet | Bongaerts, Eva Nawrot, Tim S. Van Pee, Thessa Ameloot, Marcel Bové, Hannelore |
author_sort | Bongaerts, Eva |
collection | PubMed |
description | Fetal development is a crucial window of susceptibility in which exposure may lead to detrimental health outcomes at birth and later in life. The placenta serves as a gatekeeper between mother and fetus. Knowledge regarding the barrier capacity of the placenta for nanoparticles is limited, mostly due to technical obstacles and ethical issues. We systematically summarize and discuss the current evidence and define knowledge gaps concerning the maternal-fetal transport and fetoplacental accumulation of (ultra)fine particles and nanoparticles. We included 73 studies on placental translocation of particles, of which 21 in vitro/ex vivo studies, 50 animal studies, and 2 human studies on transplacental particle transfer. This systematic review shows that (i) (ultra)fine particles and engineered nanoparticles can bypass the placenta and reach fetal units as observed for all the applied models irrespective of the species origin (i.e., rodent, rabbit, or human) or the complexity (i.e., in vitro, ex vivo, or in vivo), (ii) particle size, particle material, dose, particle dissolution, gestational stage of the model, and surface composition influence maternal-fetal translocation, and (iii) no simple, standardized method for nanoparticle detection and/or quantification in biological matrices is available to date. Existing evidence, research gaps, and perspectives of maternal-fetal particle transfer are highlighted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12989-020-00386-8. |
format | Online Article Text |
id | pubmed-7607677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76076772020-11-03 Translocation of (ultra)fine particles and nanoparticles across the placenta; a systematic review on the evidence of in vitro, ex vivo, and in vivo studies Bongaerts, Eva Nawrot, Tim S. Van Pee, Thessa Ameloot, Marcel Bové, Hannelore Part Fibre Toxicol Review Fetal development is a crucial window of susceptibility in which exposure may lead to detrimental health outcomes at birth and later in life. The placenta serves as a gatekeeper between mother and fetus. Knowledge regarding the barrier capacity of the placenta for nanoparticles is limited, mostly due to technical obstacles and ethical issues. We systematically summarize and discuss the current evidence and define knowledge gaps concerning the maternal-fetal transport and fetoplacental accumulation of (ultra)fine particles and nanoparticles. We included 73 studies on placental translocation of particles, of which 21 in vitro/ex vivo studies, 50 animal studies, and 2 human studies on transplacental particle transfer. This systematic review shows that (i) (ultra)fine particles and engineered nanoparticles can bypass the placenta and reach fetal units as observed for all the applied models irrespective of the species origin (i.e., rodent, rabbit, or human) or the complexity (i.e., in vitro, ex vivo, or in vivo), (ii) particle size, particle material, dose, particle dissolution, gestational stage of the model, and surface composition influence maternal-fetal translocation, and (iii) no simple, standardized method for nanoparticle detection and/or quantification in biological matrices is available to date. Existing evidence, research gaps, and perspectives of maternal-fetal particle transfer are highlighted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12989-020-00386-8. BioMed Central 2020-11-02 /pmc/articles/PMC7607677/ /pubmed/33138843 http://dx.doi.org/10.1186/s12989-020-00386-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Bongaerts, Eva Nawrot, Tim S. Van Pee, Thessa Ameloot, Marcel Bové, Hannelore Translocation of (ultra)fine particles and nanoparticles across the placenta; a systematic review on the evidence of in vitro, ex vivo, and in vivo studies |
title | Translocation of (ultra)fine particles and nanoparticles across the placenta; a systematic review on the evidence of in vitro, ex vivo, and in vivo studies |
title_full | Translocation of (ultra)fine particles and nanoparticles across the placenta; a systematic review on the evidence of in vitro, ex vivo, and in vivo studies |
title_fullStr | Translocation of (ultra)fine particles and nanoparticles across the placenta; a systematic review on the evidence of in vitro, ex vivo, and in vivo studies |
title_full_unstemmed | Translocation of (ultra)fine particles and nanoparticles across the placenta; a systematic review on the evidence of in vitro, ex vivo, and in vivo studies |
title_short | Translocation of (ultra)fine particles and nanoparticles across the placenta; a systematic review on the evidence of in vitro, ex vivo, and in vivo studies |
title_sort | translocation of (ultra)fine particles and nanoparticles across the placenta; a systematic review on the evidence of in vitro, ex vivo, and in vivo studies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607677/ https://www.ncbi.nlm.nih.gov/pubmed/33138843 http://dx.doi.org/10.1186/s12989-020-00386-8 |
work_keys_str_mv | AT bongaertseva translocationofultrafineparticlesandnanoparticlesacrosstheplacentaasystematicreviewontheevidenceofinvitroexvivoandinvivostudies AT nawrottims translocationofultrafineparticlesandnanoparticlesacrosstheplacentaasystematicreviewontheevidenceofinvitroexvivoandinvivostudies AT vanpeethessa translocationofultrafineparticlesandnanoparticlesacrosstheplacentaasystematicreviewontheevidenceofinvitroexvivoandinvivostudies AT amelootmarcel translocationofultrafineparticlesandnanoparticlesacrosstheplacentaasystematicreviewontheevidenceofinvitroexvivoandinvivostudies AT bovehannelore translocationofultrafineparticlesandnanoparticlesacrosstheplacentaasystematicreviewontheevidenceofinvitroexvivoandinvivostudies |